Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지

Association of the COMT Gene Polymorphism with the Risk of Endometriosis in Korean Women

한국여성에서 자궁내막증의 발생위험도와 Catechol-O-Methyltransferase 유전자 다형성과의 관련성에 관한 연구

  • Lee, Sa-Ra (Department of Obstetrics and Gynecology, College of Medicine, Ewha woman's University) ;
  • Lee, So-Hyun (Department of Obstetrics and Gynecology, College of Medicine, Ewha woman's University) ;
  • Lee, Woon-Jeong (Department of Obstetrics and Gynecology, College of Medicine, Ewha woman's University) ;
  • Hur, Sung-Eun (Department of Obstetrics and Gynecology, College of Medicine, Ewha woman's University) ;
  • Lee, Ji-Young (Department of Obstetrics and Gynecology, Konkuk University Hospital) ;
  • Moon, Hye-Sung (Department of Obstetrics and Gynecology, College of Medicine, Ewha woman's University) ;
  • Chung, Hye-Won (Department of Obstetrics and Gynecology, College of Medicine, Ewha woman's University)
  • 이사라 (이화여자대학교 의과대학 산부인과학교실) ;
  • 이소현 (이화여자대학교 의과대학 산부인과학교실) ;
  • 이운정 (이화여자대학교 의과대학 산부인과학교실) ;
  • 허성은 (이화여자대학교 의과대학 산부인과학교실) ;
  • 이지영 (건국대학교 산부인과학교실) ;
  • 문혜성 (이화여자대학교 의과대학 산부인과학교실) ;
  • 정혜원 (이화여자대학교 의과대학 산부인과학교실)
  • Published : 2004.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To investigate whether polymorphism of gene encoding COMT is associated with the risk of endometriosis in Korean women. Methods: We investigated 136 patients with histopathologically confirmed endometriosis rAFS stage III/IV and 251 control group women who were surgically proven to have no endometriosis. Polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) of PCR products were done to determine each participant's COMT genotype. Results: The distribution according to NIaIII genetic polymorphisms of COMT were as follows. $COMT^{HH}$, $COMT^{HL}$, and $COMT^{LL}$ genotypes were 56.6% (77 women), 34.6% (47 women) and 8.8% (12 women) in the study group and 50.6% (127 women), 39.4% (99 women) and 10.0% (25 women) in the control group. There was no significant difference between the study group and the control group. Conclusion: The results suggest that COMT genetic polymorphism may not be associated with the development of endometriosis in Korean women.

Keywords

References

  1. Kennedy S. Is there a genetic basis to endometriosis? Semin Reprod Endocrinol 1997; 15: 309-18 https://doi.org/10.1055/s-2008-1068761
  2. Simpson JL, Elias S, Malinak LR, Buttram VC Jr. Heritable aspects of endometriosis. Am J Obstet Gynecol 1980; 137: 327-31
  3. Treolar SA, O'Connor DT, O'Connor VM, Martin NG. Fertil Steril 1985; 71: 701-10
  4. Carey AH, Walterworth D, Patel K, White D, Little J, Novelli P, et al. Polycystic ovaries andpremature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994; 3: 1873-6 https://doi.org/10.1093/hmg/3.10.1873
  5. Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Fushiki S, Honjo H. Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil Steril 1999; 72: 1100-6 https://doi.org/10.1016/S0015-0282(99)00424-0
  6. Grossman MH, Emanuel BS, Budarf ML. Chromosomal mapping of the human catechol-O methyltransferase gene to 22q11.1----q11.2. Genomics 1992; 12: 822-5 https://doi.org/10.1016/0888-7543(92)90316-K
  7. Lundstrom K, Salminen M, Jalanko A, Savolainen R, Ulmanen I. Cloning and characterization of human placental catechol-O-methyltransferase cDNA. DNA Cell Biol 1991; 10: 181-9 https://doi.org/10.1089/dna.1991.10.181
  8. Mannisto PI, Kaakkola S. Catechol-O-methyltransferase(COMT) : Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 1999; 51: 593-628
  9. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-50 https://doi.org/10.1097/00008571-199606000-00007
  10. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 1997; 57: 5493-712
  11. Kunugi H, Vallada HP, Sham PC, Hoda F, Arranz MJ, Li T, et al. Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatr Genet 1997; 7: 97-101 https://doi.org/10.1097/00041444-199723000-00001
  12. Syvanen AC, Tilgmann C, Rinne J, Ulmanen I. Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S‐COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland. Pharmacogenetics 1997; 7: 65-71 https://doi.org/10.1097/00008571-199702000-00009
  13. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive‐compulsive disorder. Proc Natl Acad Sci USA 1997; 94: 4572-5 https://doi.org/10.1073/pnas.94.9.4572
  14. Chen CH, Lee YR, Wei FC, Koong FJ, Hwu HG, Hsiao KJ. Association study of NlaIII and MspI genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia. Biol Psychiatry 1997; 41: 985-7 https://doi.org/10.1016/S0006-3223(97)00045-0
  15. Li T, Underhill J, Liu XH, Sham PC, Donaldson P, Murray RM, et al. Transmission disequilibrium analysis of HLA class II DRB1, DQA1, DQB1 and DPB1 polymorphisms in schizophrenia using family trios from a Han Chinese population. Schizophr Res 2001; 49: 73-8 https://doi.org/10.1016/S0920-9964(00)00111-0
  16. Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N, et al. Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology 2002; 27: 607-19
  17. Vandenberg DJ, Rodriquez LA, Miller IT, Uhl GR, Lachman HM. High‐activity catechol-Omethyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet 1997; 74: 439-42 https://doi.org/10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J
  18. Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, et al. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 1998; 58: 2107-10
  19. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. Breast cancer risk associated with genotype polymorphism of the estrogen‐metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 1999; 59: 4870-5
  20. Yim DS, Parkb SK, Yoo KY, Yoon KS, Chung HH, Kang HL, et al. Relationship between the Val158Met polymorphism of catechol-O-methyltransferase and breast cancer. Pharmacogenetics 2001; 11: 279-86. https://doi.org/10.1097/00008571-200106000-00001
  21. Palmatier MA, Kang AM, Kidd KK.Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 1999; 46: 557-67 https://doi.org/10.1016/S0006-3223(99)00098-0
  22. Park TW, Yoon KS, Kim JH, Park WY, Hirvonen A, Kang D. Functional catechol-O-methyl- transferase gene polymorphism and susceptibility to schizophrenia. Eur Neuropsychopharmacol 2002; 12: 299-303
  23. Wu AH, Tseng CC, Van Den Berg D, Yu MC. Tea intake, COMT genotype, and breast cancer in Asian ‐American women. Cancer Res 2003; 63: 7526-9
  24. Zondervan KT, Cardon LR, Kennedy SH. The genetic basis of endometriosis. Curr Opin Obstet Gynecol 2001; 13: 309-14 https://doi.org/10.1097/00001703-200106000-00011
  25. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998; 19: 1-27 https://doi.org/10.1093/carcin/19.1.1
  26. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 1996; 93: 9776-81 https://doi.org/10.1073/pnas.93.18.9776
  27. Liehr JG, Fang WF, Sirbasku DA, Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 1986; 24: 353-6 https://doi.org/10.1016/0022-4731(86)90080-4
  28. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, et al. Molecular origin of cancer: catechol estrogen-3, 4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA. 1997; 94: 10937-42 https://doi.org/10.1073/pnas.94.20.10937
  29. Raftogianis R, Creveling C, Weinshilboum R, Weisz J. Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr 2000; 27: 113-24
  30. Baranova H, Bothorishvilli R, Canis M, Albuisson E, Perriot S, Glowaczower E, et al. Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population. Mol Hum Reprod 1997; 3: 775-80 https://doi.org/10.1093/molehr/3.9.775
  31. Georgiou I, Syrrou M, Bouba I, Dalkalitsis N, Paschopoulos M, Navrozoglou I, et al. Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril 1999; 72: 164-6 https://doi.org/10.1016/S0015-0282(99)00198-3
  32. Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Kado N, et al. Oestrogen receptoralpha gene polymorphism is associated with endome triosis, adenomyosis and leiomyomata. Hum Reprod 2001; 16: 51-5 https://doi.org/10.1093/humrep/16.1.51
  33. Kado N, Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, et al. Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum Reprod 2002; 17: 897-902 https://doi.org/10.1093/humrep/17.4.897
  34. Weiser F, Wenzl R, Tempfer C, Worda C, Huber J, Schneeberger C. Catechol-O-Methyltransferase polymorphism and endometriosis. Assist Reprod Genet 2002; 19: 343-8 https://doi.org/10.1023/A:1016062726783
  35. Pauwels A, Schepens PJ, D'Hooghe T, Delbeke L, Dhont M, Brouwer A, et al. The risk of endometriosis and exposure to dioxins and polychlorinated biphenyls: a case‐control study of infertile women. Hum Reprod 2001; 16: 2050-5 https://doi.org/10.1093/humrep/16.10.2050
  36. 심성신, 허성은, 이경순, 문혜성, 안정자, 정혜원, 등. 해독화 효소 유전자 (GSTM1, GSTT1 and CYP1A1) 다형성과 한국인 여성의 자궁내막증의 연관성에 관한 연구. 대한산부회지 2003; 46: 403-9
  37. 김무희, 김윤수, 이사라, 허성은, 문혜성, 정혜원 등. 한국인 여성에서 자궁내막증의 감수성과 glutathione S-transferase유전자 다형성과의 연관성. 대한산부회지 2003; 46: 2403-9
  38. Baranova H, Canis M, Ivaschenko T, Albuisson E, Bothorishvilli R, Baranov V, et al. Possible involvement of arylamine N-acetyl transferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis. Mol Hum Reprod 1999; 5: 636-41 https://doi.org/10.1093/molehr/5.7.636
  39. Nakago S, Hadfield RM, Zondervan KT, Mardon H, Manek S, Weeks DE, et al. Association between endometriosis and N-acetyl transferase 2 polymorphisms in a UK population. Mol Hum Reprod 2001; 7: 1079-83 https://doi.org/10.1093/molehr/7.11.1079
  40. 최영민, 윤지성, 구승엽, 이규섭, 박성효, 장은란 등. 자궁내막증 환자에서 N-acetyltransferase 2 유전자 다형성 양상. 대한산부회지 2003; 46: 2113-7